| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | -0.14 | 5e-05 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | -0.14 | 6e-05 |
| mRNA | Compound 7d-cis | CTRPv2 | pan-cancer | AAC | -0.15 | 7e-05 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | -0.13 | 8e-05 |
| mRNA | Repligen 136 | CTRPv2 | pan-cancer | AAC | -0.15 | 8e-05 |
| mRNA | ISOX | CTRPv2 | pan-cancer | AAC | -0.13 | 9e-05 |
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | -0.14 | 9e-05 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0001 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | -0.15 | 0.0001 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0002 |